Total Payments
$8,292
2024 Payments
$610.86
Companies
26
Transactions
346
Medicare Patients
10,120
Medicare Billing
$562,490
Payment Breakdown by Category
Food & Beverage$7,699 (92.8%)
Travel$585.99 (7.1%)
Education$6.97 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,699 | 343 | 92.8% |
| Travel and Lodging | $585.99 | 2 | 7.1% |
| Education | $6.97 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,837 | 31 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,487 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,137 | 77 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $835.21 | 38 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $649.26 | 36 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $325.20 | 16 | $0 (2024) |
| Amgen Inc. | $270.31 | 15 | $0 (2024) |
| PFIZER INC. | $233.68 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $204.75 | 13 | $0 (2023) |
| Gilead Sciences, Inc. | $131.07 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $610.86 | 21 | Abbott Laboratories ($166.54) |
| 2023 | $774.07 | 37 | E.R. Squibb & Sons, L.L.C. ($183.20) |
| 2022 | $733.57 | 37 | E.R. Squibb & Sons, L.L.C. ($299.19) |
| 2021 | $729.83 | 26 | Abbott Laboratories ($196.05) |
| 2020 | $506.13 | 22 | Janssen Pharmaceuticals, Inc ($249.96) |
| 2019 | $2,277 | 83 | Abbott Laboratories ($906.45) |
| 2018 | $1,646 | 76 | Novartis Pharmaceuticals Corporation ($385.36) |
| 2017 | $1,015 | 44 | Janssen Pharmaceuticals, Inc ($331.01) |
All Payment Transactions
346 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/30/2024 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $141.70 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/18/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/08/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Structural Heart | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/06/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $44.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardiology | ||||||
| 04/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/20/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $70.99 | General |
| Category: Respiratory | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/12/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/09/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/02/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,848 | 3,422 | $583,162 | $145,721 |
| 2022 | 27 | 2,692 | 3,439 | $582,529 | $153,415 |
| 2021 | 25 | 2,559 | 2,977 | $511,220 | $138,684 |
| 2020 | 23 | 2,021 | 2,444 | $455,989 | $124,670 |
Total Patients
10,120
Total Services
12,282
Medicare Billing
$562,490
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 702 | 765 | $163,710 | $50,599 | 30.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 474 | 484 | $98,736 | $23,598 | 23.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 124 | 124 | $36,332 | $11,233 | 30.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 194 | 194 | $77,018 | $10,403 | 13.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 67 | 73 | $22,630 | $7,123 | 31.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 72 | 111 | $21,349 | $6,795 | 31.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 101 | 246 | $21,894 | $5,079 | 23.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 31 | $14,229 | $4,085 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 44 | $11,836 | $3,203 | 27.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 75 | 138 | $12,282 | $2,573 | 21.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 412 | 461 | $21,206 | $2,506 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 53 | 53 | $7,844 | $2,344 | 29.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 111 | 113 | $8,023 | $1,944 | 24.2% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 61 | 65 | $6,955 | $1,652 | 23.7% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Facility | 2023 | 33 | 60 | $10,080 | $1,635 | 16.2% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Facility | 2023 | 13 | 89 | $6,586 | $1,573 | 23.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 57 | 120 | $10,064 | $1,431 | 14.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 14 | $3,840 | $1,308 | 34.1% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 15 | 15 | $4,620 | $1,261 | 27.3% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 55 | 55 | $4,235 | $1,104 | 26.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 25 | 39 | $6,552 | $998.20 | 15.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 15 | 15 | $2,730 | $866.50 | 31.7% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 16 | $2,864 | $603.24 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,112 | $496.06 | 23.5% |
| 93279 | Programming of single lead pacemaker system | Facility | 2023 | 19 | 20 | $1,800 | $416.33 | 23.1% |
About Dr. David Tingler, M.D
Dr. David Tingler, M.D is a Internal Medicine healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124235478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Tingler, M.D has received a total of $8,292 in payments from pharmaceutical and medical device companies, with $610.86 received in 2024. These payments were reported across 346 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($7,699).
As a Medicare-enrolled provider, Tingler has provided services to 10,120 Medicare beneficiaries, totaling 12,282 services with total Medicare billing of $562,490. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Morgantown, WV
- Active Since 05/17/2007
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124235478
Products in Payments
- XARELTO (Drug) $1,612
- ENTRESTO (Drug) $918.50
- Quadra Assura CRT Defibrillator (Device) $838.95
- ELIQUIS (Drug) $785.53
- BRILINTA (Drug) $523.38
- LifeVest (Device) $325.20
- CAMZYOS (Drug) $187.57
- Repatha (Biological) $153.99
- JARDIANCE (Drug) $150.85
- GALLANT (Device) $141.70
- JOT DX (Device) $141.19
- HeartMate 3 Left Ventricular Dev (Device) $135.92
- LEQVIO (Drug) $122.65
- Corlanor (Drug) $116.32
- ATRICURE ATRICLIP LAA EXCLUSION SYSTEM (Device) $115.88
- Allure Quadra RF CRT Pacemaker (Device) $114.24
- Barostim Neo System (Device) $113.66
- Anthem CRT Pacemaker (Device) $107.58
- OPSUMIT MACITENTAN (Drug) $106.40
- Adempas (Drug) $100.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Morgantown
Dr. Partho Sengupta, Md, Dm, MD, DM
Internal Medicine — Payments: $152,664
Internal Medicine $152,664
Dr. Ashkan Emadi, Md, Phd, MD, PHD
Internal Medicine — Payments: $123,347
Internal Medicine $123,347
Dr. Latoya Linton-Frazier, Md, MD
Internal Medicine — Payments: $72,467
Internal Medicine $72,467
Ward Paine, Md, MD
Internal Medicine — Payments: $69,016
Internal Medicine $69,016
Dr. John Nasr, Md, MD
Internal Medicine — Payments: $35,066
Internal Medicine $35,066
Dr. Matthew Gaskill, D.o, D.O
Internal Medicine — Payments: $21,227
Internal Medicine $21,227